Skip to Content

Monoclonal Antibody Therapeutics: Challenges for the Clinical Laboratory

Expires October 23, 2021


Video length: 55 minutes

In this month’s “Virtual Lecture,” Melissa Snyder, Ph.D., shares information on therapeutic monoclonal antibodies, therapeutic MAb quantitation, and their immunogenicity assessment.


Upon completion of this program, participants should be able to:

  • List the classes of therapeutic monoclonal antibodies and define their characteristics.
  • Describe the available methods for measuring therapeutic monoclonal antibodies and assessing anti-drug antibodies.
  • Discuss how results from therapeutic monoclonal antibody and anti-drug antibody testing impact patient management.

Intended Audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.


Melissa Snyder, Ph.D.
Associate Professor of Laboratory Medicine and Pathology
Division of Clinical Biochemistry
Mayo Clinic, Rochester, Minnesota


The following types of credit are offered for this program:

State of California
State of Florida

To obtain credit:

  1. Watch the video.
  2. Complete the posttest and evaluation that launches immediately following the video.
  3. Generate and print your certificate(s).

Level of instruction for this program is intermediate.


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of California

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1.0 contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General (Clinical Chemistry/UA/Toxicology) credit. This program has been approved 1.0 contact hour.

Faculty Disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

MCL Education

MCL Education

This post was developed by our Education and Technical Publications Team.